These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 9783939)
1. The effect of prostate volume on the yield of needle biopsy. Letran JL; Meyer GE; Loberiza FR; Brawer MK J Urol; 1998 Nov; 160(5):1718-21. PubMed ID: 9783939 [TBL] [Abstract][Full Text] [Related]
2. Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection. Eskicorapci SY; Guliyev F; Akdogan B; Dogan HS; Ergen A; Ozen H J Urol; 2005 May; 173(5):1536-40. PubMed ID: 15821481 [TBL] [Abstract][Full Text] [Related]
3. High yield of saturation prostate biopsy for patients with previous negative biopsies and small prostates. Sajadi KP; Kim T; Terris MK; Brown JA; Lewis RW Urology; 2007 Oct; 70(4):691-5. PubMed ID: 17991539 [TBL] [Abstract][Full Text] [Related]
4. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients. Guichard G; Larré S; Gallina A; Lazar A; Faucon H; Chemama S; Allory Y; Patard JJ; Vordos D; Hoznek A; Yiou R; Salomon L; Abbou CC; de la Taille A Eur Urol; 2007 Aug; 52(2):430-5. PubMed ID: 17412489 [TBL] [Abstract][Full Text] [Related]
5. Importance of peripheral biopsies in maximising the detection of early prostate cancer in repeat 12-core biopsy protocols. Philip J; Hanchanale V; Foster CS; Javlé P BJU Int; 2006 Sep; 98(3):559-62. PubMed ID: 16925754 [TBL] [Abstract][Full Text] [Related]
6. Examination of the 3 molecular forms of serum prostate specific antigen for distinguishing negative from positive biopsy: relationship to transition zone volume. Stamey TA; Yemoto CE J Urol; 2000 Jan; 163(1):119-26. PubMed ID: 10604328 [TBL] [Abstract][Full Text] [Related]
7. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. Stewart CS; Leibovich BC; Weaver AL; Lieber MM J Urol; 2001 Jul; 166(1):86-91; discussion 91-2. PubMed ID: 11435830 [TBL] [Abstract][Full Text] [Related]
8. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer. Noguchi M; Stamey TA; McNeal JE; Yemoto CM J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833 [TBL] [Abstract][Full Text] [Related]
9. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme. Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847 [TBL] [Abstract][Full Text] [Related]
10. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484 [TBL] [Abstract][Full Text] [Related]
11. Significance of lateral biopsy specimens during transrectal ultrasound-guided prostate biopsies in Japanese men. Shigemura K; Arakawa S; Yamanaka K; Kataoka N; Yuien K; Fujisawa M Int J Urol; 2007 Oct; 14(10):935-8. PubMed ID: 17880293 [TBL] [Abstract][Full Text] [Related]
12. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. Presti JC; Chang JJ; Bhargava V; Shinohara K J Urol; 2000 Jan; 163(1):163-6; discussion 166-7. PubMed ID: 10604337 [TBL] [Abstract][Full Text] [Related]
13. Prostate biopsy: who, how and when. An update. Djavan B; Milani S; Remzi M Can J Urol; 2005 Feb; 12 Suppl 1():44-8; discussion 99-100. PubMed ID: 15780165 [TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? Djavan B; Ravery V; Zlotta A; Dobronski P; Dobrovits M; Fakhari M; Seitz C; Susani M; Borkowski A; Boccon-Gibod L; Schulman CC; Marberger M J Urol; 2001 Nov; 166(5):1679-83. PubMed ID: 11586201 [TBL] [Abstract][Full Text] [Related]
15. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study. Djavan B; Mazal P; Zlotta A; Wammack R; Ravery V; Remzi M; Susani M; Borkowski A; Hruby S; Boccon-Gibod L; Schulman CC; Marberger M Prostate; 2001 May; 47(2):111-7. PubMed ID: 11340633 [TBL] [Abstract][Full Text] [Related]
16. Outcome of sextant biopsy according to gland volume. Karakiewicz PI; Bazinet M; Aprikian AG; Trudel C; Aronson S; Nachabé M; Péloquint F; Dessureault J; Goyal MS; Bégin LR; Elhilali MM Urology; 1997 Jan; 49(1):55-9. PubMed ID: 9000186 [TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced gray-scale transrectal ultrasound-guided prostate biopsy in men with elevated serum prostate-specific antigen levels. Yang JC; Tang J; Li J; Luo Y; Li Y; Shi H Acad Radiol; 2008 Oct; 15(10):1291-7. PubMed ID: 18790401 [TBL] [Abstract][Full Text] [Related]
18. Does increased needle biopsy sampling of the prostate detect a higher number of potentially insignificant tumors? Chan TY; Chan DY; Stutzman KL; Epstein JI J Urol; 2001 Dec; 166(6):2181-4. PubMed ID: 11696731 [TBL] [Abstract][Full Text] [Related]
19. Effect of prostate volume on tumor grade in patients undergoing radical prostatectomy in the era of extended prostatic biopsies. Kassouf W; Nakanishi H; Ochiai A; Babaian KN; Troncoso P; Babaian RJ J Urol; 2007 Jul; 178(1):111-4. PubMed ID: 17499289 [TBL] [Abstract][Full Text] [Related]
20. Epididymitis after transrectal ultrasound-guided needle biopsy of prostate gland. Donzella JG; Merrick GS; Lindert DJ; Andreini HJ; Curtis RL; Luna IH; Allen Z; Butler WM Urology; 2004 Feb; 63(2):306-8. PubMed ID: 14972477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]